eCite Digital Repository
The potential for intelligent decision support systems to improve the quality and consistency of medication reviews
Citation
Bindoff, I and Stafford, A and Peterson, G and Kang, BH and Tenni, P, The potential for intelligent decision support systems to improve the quality and consistency of medication reviews, Journal of Clinical Pharmacy and Therapeutics, 37, (4) pp. 452-458. ISSN 0269-4727 (2012) [Refereed Article]
Copyright Statement
Copyright 2011 Blackwell Publishing Ltd
DOI: doi:10.1111/j.1365-2710.2011.01327.x
Abstract
What is known and Objective: Drug-related problems (DRPs)
are of serious concern worldwide, particularly for the elderly
who often take many medications simultaneously. Medication
reviews have been demonstrated to improve medication usage,
leading to reductions in DRPs and potential savings in healthcare
costs. However, medication reviews are not always of a
consistently high standard, and there is often room for
improvement in the quality of their findings. Our aim was to
produce computerized intelligent decision support software
that can improve the consistency and quality of medication
review reports, by helping to ensure that DRPs relevant to a
patient are overlooked less frequently. A system that largely
achieved this goal was previously published, but refinements
have been made. This paper examines the results of both the
earlier and newer systems.
Methods: Two prototype multiple-classification ripple-down
rules medication review systems were built, the second being a
refinement of the first. Each of the systems was trained incrementally
using a human medication review expert. The resultant
knowledge bases were analysed and compared, showing factors
such as accuracy, time taken to train, and potential errors
avoided.
Results and Discussion: The two systems performed well,
achieving accuracies of approximately 80% and 90%, after
being trained on only a small number of cases (126 and 244
cases, respectively). Through analysis of the available data, it
was estimated that without the system intervening, the expert
training the first prototype would have missed approximately
36% of potentially relevant DRPs, and the second 43%. However,
the system appeared to prevent the majority of these
potential expert errors by correctly identifying the DRPs for
them, leaving only an estimated 8% error rate for the first
expert and 4% for the second.
What is new and conclusion: These intelligent decision supsupport
systems have shown a clear potential to substantially
improve the quality and consistency of medication reviews,
which should in turn translate into improved medication
usage if they were implemented into routine use.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | artificial intelligence, decision support systems, electronic health records, medication review |
Research Division: | Biomedical and Clinical Sciences |
Research Group: | Pharmacology and pharmaceutical sciences |
Research Field: | Clinical pharmacy and pharmacy practice |
Objective Division: | Health |
Objective Group: | Evaluation of health and support services |
Objective Field: | Evaluation of health outcomes |
UTAS Author: | Bindoff, I (Dr Ivan Bindoff) |
UTAS Author: | Stafford, A (Dr Andrew Stafford) |
UTAS Author: | Peterson, G (Professor Gregory Peterson) |
UTAS Author: | Kang, BH (Professor Byeong Kang) |
UTAS Author: | Tenni, P (Dr Peter Tenni) |
ID Code: | 83091 |
Year Published: | 2012 |
Web of Science® Times Cited: | 18 |
Deposited By: | Pharmacy |
Deposited On: | 2013-03-01 |
Last Modified: | 2017-11-02 |
Downloads: | 0 |
Repository Staff Only: item control page